Engineered endothelial cells expressing an ETS transcription factor
US10961509B2 · kind B2 · utility
1Cited by
5References
12Claims
0Family size
Inventors
Key dates
| Filing date | Jul 19, 2016 |
| Grant date | Mar 30, 2021 |
| Priority date | — |
| Expiry date | Jul 19, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/15043
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In some aspects the present invention relates to engineered endothelial cells, such as E40RF1+ ETV2+ engineered endothelial cells. In other aspects the present invention relates to methods of making such engineered endothelial cells, and methods of using such engineered endothelial cells, for example in co-culture applications.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.